| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/50-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | B3Glc-T; B3GLT; B3GTL; beta 1; 3-galactosyltransferase-like |
| Entrez GeneID | 145173; |
| WB Predicted band size | 57kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthesized peptide derived from C-terminal of human B3GALTL. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于B3GALTL抗体的3篇参考文献的简要列举：
---
1. **文献名称**: *Mutations in the β3-glucosyltransferase gene (B3GALTL) cause autosomal-recessive Peters plus syndrome*
**作者**: Heinonen TYK, et al.
**摘要内容**: 该研究首次将B3GALTL基因突变与彼得斯加综合征(Peters plus syndrome)关联，利用特异性抗体检测患者细胞中B3GALTL蛋白的表达缺失，证实其参与胶原糖基化修饰异常导致的发育缺陷。
---
2. **文献名称**: *Functional analysis of B3GALTL mutations in Peters plus syndrome*
**作者**: Weh E, et al.
**摘要内容**: 通过构建B3GALTL突变体细胞模型，采用Western blot和免疫荧光技术结合抗体，揭示突变导致酶活性丧失及细胞外基质糖蛋白合成障碍，解释了眼部和全身表型的分子机制。
---
3. **文献名称**: *B3GALTL regulates O-fucosylation of thrombospondin type 1 repeats*
**作者**: Allen WJ, et al.
**摘要内容**: 研究利用B3GALTL抗体进行蛋白定位和表达分析，发现其在调控血小板反应蛋白TSP1结构域的O-连接岩藻糖基化中起关键作用，为相关先天性疾病的治疗提供潜在靶点。
---
上述文献均涉及B3GALTL抗体的应用(如蛋白表达检测、功能验证等)，并围绕其基因功能及与疾病的关联展开。具体年份可能需通过数据库核实，但核心内容符合研究方向。
The B3GALTL antibody targets the β-1.3-galactosyltransferase-like (B3GALTL) protein, encoded by the *B3GALTL* gene. This enzyme is critical in glycosylation pathways, specifically catalyzing the transfer of glucose to O-linked fucosyl residues on thrombospondin type-1 repeats (TSRs) of secreted proteins. This post-translational modification is essential for protein folding, stability, and functional maturation. B3GALTL mutations are linked to Peters Plus Syndrome, a rare autosomal recessive disorder characterized by ocular anomalies, developmental delays, and skeletal defects, underscoring the gene's role in developmental biology.
B3GALTL antibodies are valuable tools for studying glycosylation mechanisms, protein trafficking, and disease pathogenesis. They enable detection of B3GALTL expression in tissues or cell lines via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Researchers also use these antibodies to investigate dysregulation in congenital disorders or cancers where aberrant glycosylation is implicated. Commercial antibodies are typically raised in rabbits or mice, with validation in knockout models to ensure specificity. Recent studies focus on B3GALTL's interaction with substrates like ADAMTS family proteins, highlighting its broader impact on extracellular matrix biology and therapeutic potential.
×
